Accelerated approval of semaglutide 7.2 mg establishes a higher-dose, once-weekly GLP-1 RA option for long-term weight reduction under the FDA’s National Priority Voucher framework. STEP UP (n=1407) ...
By HealthDay Staff HealthDay ReporterTHURSDAY, April 2, 2026 (HealthDay News) — A new daily pill to help with weight loss has ...
MedPage Today on MSN
Speeding Up Approvals, Getting More Drugs OTC Among FDA's Top Priorities
"We can do better," commissioner says ...
Montage is still awaiting FDA approval of its Wireless Healthphone, which is meant to send patient data wirelessly to doctors and other caregivers. Healthphone includes blood glucose monitoring ...
(CNN) — A senior Food and Drug Administration official on Friday said the agency will change its vaccine approval process, alleging that Covid-19 vaccination resulted in the deaths of 10 children. In ...
A commentary by FDA officials Vinay Prasad, MD, MPH, and Martin Makary, MD, MPH, details the new system for drug approvals in the US. FDA Commissioner Martin Makary, MD, MPH, and his top deputy Vinay ...
The daily pill, called Foundayo, is the second oral GLP-1 product to reach the market over the past few months.
The US regulator has approved Eli Lilly's new oral weight-loss drug Foundayo through a fast-track process, offering a more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results